Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod.
An official website of the United States government
A .gov website belongs to an official government organization in the United States.
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Product: Hyper-Immune Plasma Yield
Description of Project: Plasma Technologies was contracted to develop and optimize a process to produce higher yielding anti-COVID-19 immune serum for scale-up and manufacturing.
Unique Impact: If successful, a higher yield hyperimmune serum would be an improvement over the current standard method. Convalescent plasma, which is collected from a person who has recovered from a disease, may be beneficial in the treatment of patients suffering from COVID-19.
Base Award Amount: $741,925.00
Category: Therapeutics Supplies and Raw Materials
ASPR's IBx Portfolio
